Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease

Lipocalin-2 (LCN2) is an inflammatory protein with diverse functions in the brain. Although many studies have investigated the mechanism of LCN2 in brain injuries, the effect of LCN2 on amyloid-toxicity-related memory deficits in a mouse model of Alzheimer’s disease (AD) has been less studied. We in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heeyoung Kang, Hyun Joo Shin, Hyeong Seok An, Zhen Jin, Jong Youl Lee, Jaewoong Lee, Kyung Eun Kim, Eun Ae Jeong, Kyu Yeong Choi, Catriona McLean, Kun Ho Lee, Soo Kyoung Kim, Hae Ryong Lee, Gu Seob Roh
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/aaf140224e9448f881a85a7c3a05ad81
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aaf140224e9448f881a85a7c3a05ad81
record_format dspace
spelling oai:doaj.org-article:aaf140224e9448f881a85a7c3a05ad812021-11-25T16:25:29ZRole of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease10.3390/antiox101116572076-3921https://doaj.org/article/aaf140224e9448f881a85a7c3a05ad812021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1657https://doaj.org/toc/2076-3921Lipocalin-2 (LCN2) is an inflammatory protein with diverse functions in the brain. Although many studies have investigated the mechanism of LCN2 in brain injuries, the effect of LCN2 on amyloid-toxicity-related memory deficits in a mouse model of Alzheimer’s disease (AD) has been less studied. We investigated the role of LCN2 in human AD patients using a mouse model of AD. We created an AD mouse model by injecting amyloid-beta oligomer (AβO) into the hippocampus. In this model, animals exhibited impaired learning and memory. We found LCN2 upregulation in the human brain frontal lobe, as well as a positive correlation between white matter ischemic changes and serum LCN2. We also found increased astrocytic LCN2, microglia activation, iron accumulation, and blood–brain barrier disruption in AβO-treated hippocampi. These findings suggest that LCN2 is involved in a variety of amyloid toxicity mechanisms, especially neuroinflammation and oxidative stress.Heeyoung KangHyun Joo ShinHyeong Seok AnZhen JinJong Youl LeeJaewoong LeeKyung Eun KimEun Ae JeongKyu Yeong ChoiCatriona McLeanKun Ho LeeSoo Kyoung KimHae Ryong LeeGu Seob RohMDPI AGarticlelipocalin-2amyloid-betaneuroinflammationiron accumulationoxidative stressblood–brain barrier leakageTherapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1657, p 1657 (2021)
institution DOAJ
collection DOAJ
language EN
topic lipocalin-2
amyloid-beta
neuroinflammation
iron accumulation
oxidative stress
blood–brain barrier leakage
Therapeutics. Pharmacology
RM1-950
spellingShingle lipocalin-2
amyloid-beta
neuroinflammation
iron accumulation
oxidative stress
blood–brain barrier leakage
Therapeutics. Pharmacology
RM1-950
Heeyoung Kang
Hyun Joo Shin
Hyeong Seok An
Zhen Jin
Jong Youl Lee
Jaewoong Lee
Kyung Eun Kim
Eun Ae Jeong
Kyu Yeong Choi
Catriona McLean
Kun Ho Lee
Soo Kyoung Kim
Hae Ryong Lee
Gu Seob Roh
Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
description Lipocalin-2 (LCN2) is an inflammatory protein with diverse functions in the brain. Although many studies have investigated the mechanism of LCN2 in brain injuries, the effect of LCN2 on amyloid-toxicity-related memory deficits in a mouse model of Alzheimer’s disease (AD) has been less studied. We investigated the role of LCN2 in human AD patients using a mouse model of AD. We created an AD mouse model by injecting amyloid-beta oligomer (AβO) into the hippocampus. In this model, animals exhibited impaired learning and memory. We found LCN2 upregulation in the human brain frontal lobe, as well as a positive correlation between white matter ischemic changes and serum LCN2. We also found increased astrocytic LCN2, microglia activation, iron accumulation, and blood–brain barrier disruption in AβO-treated hippocampi. These findings suggest that LCN2 is involved in a variety of amyloid toxicity mechanisms, especially neuroinflammation and oxidative stress.
format article
author Heeyoung Kang
Hyun Joo Shin
Hyeong Seok An
Zhen Jin
Jong Youl Lee
Jaewoong Lee
Kyung Eun Kim
Eun Ae Jeong
Kyu Yeong Choi
Catriona McLean
Kun Ho Lee
Soo Kyoung Kim
Hae Ryong Lee
Gu Seob Roh
author_facet Heeyoung Kang
Hyun Joo Shin
Hyeong Seok An
Zhen Jin
Jong Youl Lee
Jaewoong Lee
Kyung Eun Kim
Eun Ae Jeong
Kyu Yeong Choi
Catriona McLean
Kun Ho Lee
Soo Kyoung Kim
Hae Ryong Lee
Gu Seob Roh
author_sort Heeyoung Kang
title Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
title_short Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
title_full Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
title_fullStr Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
title_full_unstemmed Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
title_sort role of lipocalin-2 in amyloid-beta oligomer-induced mouse model of alzheimer’s disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/aaf140224e9448f881a85a7c3a05ad81
work_keys_str_mv AT heeyoungkang roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT hyunjooshin roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT hyeongseokan roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT zhenjin roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT jongyoullee roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT jaewoonglee roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT kyungeunkim roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT eunaejeong roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT kyuyeongchoi roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT catrionamclean roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT kunholee roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT sookyoungkim roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT haeryonglee roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
AT guseobroh roleoflipocalin2inamyloidbetaoligomerinducedmousemodelofalzheimersdisease
_version_ 1718413218868625408